| Literature DB >> 24578539 |
Nativitat Ortells-Abuye1, Teresa Busquets-Puigdevall, Maribel Díaz-Bergara, Marta Paguina-Marcos, Inma Sánchez-Pérez.
Abstract
OBJECTIVES: To demonstrate the equivalence between blood collection methods using direct venous puncture (DVP) and a peripheral venous catheter or cannula (PVC). DESIGN ANDEntities:
Keywords: General Medicine (see Internal Medicine); Haematology
Mesh:
Year: 2014 PMID: 24578539 PMCID: PMC3939659 DOI: 10.1136/bmjopen-2013-004250
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Description of the study population at the time of collection by direct venous puncture and peripheral venous catheter (n=272)
| Variable | n | Per cent | 95% CI |
|---|---|---|---|
| Age (years) | |||
| ≥65 | 220 | 80.9 | (75.8 to 85.1) |
| Sex | |||
| Male | 143 | 52.6 | (46.6 to 58.4) |
| Diagnosis | |||
| Cardiorespiratory | 109 | 40.1 | (34.3 to 46.0) |
| Cerebrovascular | 14 | 5.1 | (3.1 to 8.5) |
| Gastrointestinal | 68 | 25.0 | (20.2 to 30.5) |
| Genitourinary | 28 | 10.3 | (7.2 to 14.5) |
| Osteomuscular | 29 | 10.7 | (7.5 to 14.9) |
| Other | 24 | 8.8 | (6.0 to 12.8) |
| Vein location for DVP | |||
| Hand | 2 | 0.7 | (0.2 to 2.6) |
| Wrist | 4 | 1.5 | (0.6 to 3.7) |
| Forearm | 6 | 2.2 | (1.0 to 4.7) |
| Inner arm | 260 | 95.6 | (92.4 to 97.5) |
| Location of the PVC | |||
| Hand | 17 | 6.3 | (3.9 to to 9.8) |
| Wrist | 68 | 25.0 | (20.2 to 30.5) |
| Forearm | 66 | 24.3 | (19.6 to 29.7) |
| Inner arm | 121 | 44.5 | (38.7 to 50.4) |
| PVC calibre (gauges) | |||
| 16 | 2 | 0.7 | (0.2 to 2.6) |
| 18 | 50 | 18.4 | (14.2 to 23.4) |
| 20 | 202 | 74.3 | (68.8 to 79.1) |
| 22 | 18 | 6.6 | (4.2 to 10.2) |
| Saline syringe | |||
| No | 223 | 82.0 | (77.0 to 86.1) |
| Intravenous fluid therapy* | 192 | 70.6 | (64.9 to 75.7) |
| Saline solution | 85 | 31.3 | (26.0 to 37.0) |
| 5% Glucose solution | 45 | 16.5 | (12.6 to 21.4) |
| Glucosaline solution | 94 | 34.6 | (29.2 to 40.4) |
| Isoplasmal | 9 | 3.3 | (1.8 to 6.2) |
| Ringer's | 1 | 0.4 | (0.1 to 2.1) |
| Medication* | |||
| Perfusion | 24 | 8.8 | (6.0 to 12.8) |
| Intermittent | 118 | 43.4 | (37.6 to 49.3) |
| Haemolysis during DVP collection | |||
| Yes | 0 | 0.0 | (0.0 to 1.4) |
| Haemolysis during PVC collection | |||
| Yes | 10 | 3.7 | (2.0 to 6.6) |
| Clotted blood during DVP collection | |||
| Yes | 2 | 0.7 | (0.2 to 2.6) |
| Clotted blood during PVC collection | |||
| Yes | 1 | 0.4 | (0.1 to 2.1) |
*Non-exclusive categories.
DVP, direct venous puncture; PVC, peripheral venous catheter.
Linear association, concordance and equivalence between the findings obtained by direct venous puncture and peripheral venous catheter
| Determination | Variable | N | r | rc | Clinically accepted interval | Agreement interval | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAI | n | Per cent | 95% CI | 95% AI | n | Per cent | 95% CI | |||||
| Biochemistry | Amylase (U/L) | 265 | 0.999 | 0.996 | (−20 to −20) | 1 | 0.4 | (0.1 to −2.1) | (−34.09 to −36.10) | 1 | 0.4 | (0.1 to −2.1) |
| Calcium (mg/dL) | 266 | 0.899 | 0.860 | (−1 to −1) | 2 | 0.8 | (0.2 to −2.7) | (−0.90 to −0.44) | 7 | 2.6 | (1.3 to −5.3) | |
| Total cholesterol (mg/dL) | 269 | 0.984 | 0.983 | (−10 to −10) | 12 | 4.5 | (2.6 to −7.6) | (−13.64 to −15.56) | 6 | 2.2 | (1.0 to −4.8) | |
| Creatinine (mg/dL) | 271 | 0.982 | 0.982 | (−0.3 to −0.3) | 4 | 1.5 | (0.6 to −3.7) | (−0.25 to −0.27) | 4 | 1.5 | (0.6 to −3.7) | |
| Creatine kinase (U/L) | 262 | 0.999 | 0.999 | (−20 to −20) | 13 | 5.0 | (2.9 to −8.3) | (−28.76 to −25.49) | 9 | 3.4 | (1.8 to −6.4) | |
| Basal glucose (mg/dL) | 272 | 0.960 | 0.957 | (−15 to −15) | 17 | 6.3 | (3.9 to −9.8) | (−34.69 to −26.66) | 9 | 3.3 | (1.8 to −6.2) | |
| Aspartate aminotransferase (SGOT) (U/L) | 269 | 0.998 | 0.998 | (−10 to −10) | 7 | 2.6 | (1.3 to −5.3) | (−8.86 to −7.47) | 11 | 4.1 | (2.3 to −7.2) | |
| Potassium (mEq/L) | 269 | 0.937 | 0.936 | (−0.4 to −0.4) | 19 | 7.1 | (4.6 to −10.8) | (−0.45 to −0.45) | 13 | 4.8 | (2.8 to −8.1) | |
| Sodium (mEq/L) | 271 | 0.950 | 0.950 | (−4 to −4) | 4 | 1.5 | (0.6 to −3.7) | (−2.63 to −3.11) | 12 | 4.4 | (2.6 to −7.6) | |
| Urea (mg/dL) | 269 | 0.997 | 0.997 | (−5 to −5) | 9 | 3.3 | (1.8 to −6.2) | (−6.65 to −6.94) | 7 | 2.6 | (1.3 to −5.3) | |
| Haematology | Red blood cells (106/μL) | 268 | 0.988 | 0.988 | (−0.5 to −0.5) | 3 | 1.1 | (0.4 to −3.2) | (−0.22 to −0.22) | 12 | 4.5 | (2.6 to −7.7) |
| Haemoglobin (g/dL) | 268 | 0.986 | 0.986 | (−0.6 to −0.6) | 9 | 3.4 | (1.8 to −6.3) | (−0.65 to −0.65) | 8 | 3.0 | (1.5 to −5.8) | |
| Leucocytes (103/μL) | 268 | 0.983 | 0.983 | (−2 to −2) | 4 | 1.5 | (0.6 to − to 3.8) | (−1.78 to −1.75) | 5 | 1.9 | (0.8 to −4.3) | |
| Platelets (103/μL) | 267 | 0.982 | 0.982 | (−50 to −50) | 3 | 1.1 | (0.4 to −3.3) | (−30.32 to −34.37) | 7 | 2.6 | (1.3 to −5.3) | |
| Prothrombin ratio (%) | 269 | 0.918 | 0.917 | (−7 to −) | 22 | 8.2 | (5.5 to −12.1) | (−16.63 to −19.14) | 5 | 1.9 | (0.8 to −4.3) | |
| Blood gas | Venous carbon dioxide potential (pH) | 260 | 0.862 | 0.853 | (−0.1 to −0.1) | 2 | 0.8 | (0.2 to −2.8) | (−0.06 to −0.04) | 11 | 4.2 | (2.4 to −7.4) |
| Venous carbon dioxide partial pressure (pCO2) (mm Hg) | 260 | 0.875 | 0.843 | (−5 to −5) | 55 | 21.2 | (16.6 to −26.5) | (−6.14 to −10.51) | 10 | 3.8 | (2.1 to −6.9) | |
| Venous oxygen partial pressure (pO2) (mm Hg) | 260 | 0.405 | 0.336 | (−5 to −5) | 190 | 73.1 | (67.4 to −78.1) | (−40.60 to −22.08) | 10 | 3.8 | (2.1 to −6.9) | |
N, Number of tests with valid findings for direct venous puncture (DVP) and peripheral venous catheter (PVC); n, Number of tests showing differences between DVP and PVC greater than the interval; r, Pearson's product-moment correlation coefficient; rc, Lin's concordance correlation coefficient; CAI, interval defined by the minimal clinically significant difference (according to investigators) between DVP and PVC; 95% AI, interval of agreement of 95% according to the Bland-Altman method: mean difference between methods±1.96 SD of the difference; 95% CI, CI of 95% for proportion according to the Wilson score method.